PTC Therapeutics
PTCT
#2644
Rank
NZ$11.87 B
Marketcap
NZ$143.12
Share price
-4.23%
Change (1 day)
77.70%
Change (1 year)

PTC Therapeutics (PTCT) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$5.07 Billion

According to PTC Therapeutics 's latest financial reports the company's total assets are NZ$5.07 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

PTC Therapeutics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$5.00 B65.56%
2024-12-31NZ$3.02 B0.85%
2023-12-31NZ$2.99 B11.58%
2022-12-31NZ$2.68 B-5.32%
2021-12-31NZ$2.83 B-7.29%
2020-12-31NZ$3.06 B26.94%
2019-12-31NZ$2.41 B44.5%
2018-12-31NZ$1.66 B202.57%
2017-12-31NZ$0.55 B41.82%
2016-12-31NZ$0.38 B-27.14%
2015-12-31NZ$0.53 B25.49%
2014-12-31NZ$0.42 B130.07%
2013-12-31NZ$0.18 B1063.26%
2012-12-31NZ$15.89 M-71.91%
2011-12-31NZ$56.56 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
NZ$209.81 B 4,031.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$46.88 B 823.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.54 B-69.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$5.62 B 10.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.60 B-88.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$3.46 B-31.75%๐Ÿ‡บ๐Ÿ‡ธ USA